Siga Technologies (SIGA) Other Non-Current Assets (2010 - 2025)
Siga Technologies (SIGA) posted Other Non-Current Assets of $192893.0 for Q4 2025, down 4.52% on a QoQ basis from $202015.0 in Q3 2025, and down 19.86% year-over-year from $240683.0 in Q4 2024.
Siga Technologies (SIGA) Other Non-Current Assets (2010 - 2025) Analysis & Trends
Siga Technologies' Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $192893.0 for Q4 2025.
- Quarterly Other Non-Current Assets fell 19.86% year-over-year to $192893.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $192893.0 (down 19.86% YoY) and the FY2025 annual result came in at $192893.0, down 19.86% from the prior year.
- Other Non-Current Assets was $192893.0 for Q4 2025 at Siga Technologies, down from $202015.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.2 million in Q2 2024 and bottomed at $192893.0 in Q4 2025.
- A 5-year average of $822755.4 and a median of $276009.0 in 2021 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets tumbled 95.27% — and 2023, when it soared 749.77%.
- Siga Technologies' Other Non-Current Assets stood at $286585.0 in 2021, then retreated by 11.88% to $252546.0 in 2022, then jumped by 725.01% to $2.1 million in 2023, then sank by 88.45% to $240683.0 in 2024, then fell by 19.86% to $192893.0 in 2025.
- Business Quant data shows SIGA's Other Non-Current Assets at $192893.0 in Q4 2025, $202015.0 in Q3 2025, and $212696.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | 192,893.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 192,893.00 |
| Sep 30, 2025 | 202,015.00 |
| Jun 30, 2025 | 212,696.00 |
| Mar 31, 2025 | 226,485.00 |
| Dec 31, 2024 | 240,683.00 |
| Sep 30, 2024 | 253,605.00 |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.14 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 252,546.00 |
| Sep 30, 2022 | 261,814.00 |
| Jun 30, 2022 | 249,170.00 |
| Mar 31, 2022 | 265,433.00 |
| Dec 31, 2021 | 286,585.00 |
| Sep 30, 2021 | 306,722.00 |
| Jun 30, 2021 | 392,665.00 |
| Mar 31, 2021 | 419,448.00 |